From venom to precision medicine: cardiometabolic and hepatoprotective advances in incretin-based therapies

: Journal of Cardiology & Current Research
: Ney Carter do Carmo Borges

PDF Full Text

Keywords

GLP-1 receptor agonists, tirzepatide, semaglutide, mazdutide, retatrutide, obesity, MASLD, pharmacokinetics, cardiovascular outcomes, liver protection

© 2014-2025 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at www.medcrave.com
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera | Terms and Conditions | Privacy Policy

Testimonials

From venom to precision medicine: cardiometabolic and hepatoprotective advances in incretin-based therapies

Keywords

Quick Links

Related Journals